- Home
- KALV vs UP Comparison
KALV vs UP Comparison
Compare KALV & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- UP
- Stock Information
- Founded
- KALV N/A
- UP 2013
- Country
- KALV United States
- UP United States
- Employees
- KALV N/A
- UP N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- UP Aerospace
- Sector
- KALV Health Care
- UP Consumer Discretionary
- Exchange
- KALV Nasdaq
- UP Nasdaq
- Market Cap
- KALV 651.3M
- UP 1.2B
- IPO Year
- KALV N/A
- UP N/A
- Fundamental
- Price
- KALV $12.92
- UP $1.32
- Analyst Decision
- KALV Strong Buy
- UP
- Analyst Count
- KALV 8
- UP 0
- Target Price
- KALV $24.83
- UP N/A
- AVG Volume (30 Days)
- KALV 498.7K
- UP 844.1K
- Earning Date
- KALV 07-10-2025
- UP 05-01-2025
- Dividend Yield
- KALV N/A
- UP N/A
- EPS Growth
- KALV N/A
- UP N/A
- EPS
- KALV N/A
- UP N/A
- Revenue
- KALV N/A
- UP $772,533,000.00
- Revenue This Year
- KALV N/A
- UP $174.46
- Revenue Next Year
- KALV N/A
- UP N/A
- P/E Ratio
- KALV N/A
- UP N/A
- Revenue Growth
- KALV N/A
- UP N/A
- 52 Week Low
- KALV $7.30
- UP $0.74
- 52 Week High
- KALV $15.50
- UP $4.59
- Technical
- Relative Strength Index (RSI)
- KALV 60.56
- UP 47.84
- Support Level
- KALV $11.11
- UP $1.18
- Resistance Level
- KALV $11.93
- UP $1.72
- Average True Range (ATR)
- KALV 0.60
- UP 0.15
- MACD
- KALV 0.05
- UP -0.05
- Stochastic Oscillator
- KALV 80.09
- UP 23.28
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.